Proscia Inc. Overview
Pro stress-test →Proscia is a software company accelerating pathology's transition to a digital, data-driven discipline and enabling AI to advance precision medicine, with its Concentriq enterprise pathology platform, precision medicine AI portfolio, and real-world data fueling the development and use of novel therapies and diagnostics. 14 of the top 20 pharmaceutical companies and a global network of diagnostic laboratories rely on Proscia's solutions.
Strategic Profile
Pro stress-test →Proscia is biopharma's partner of choice to put pathology AI into practice. The company leverages an open-architecture platform that integrates AI solutions across drug discovery, clinical trials, companion diagnostics, and diagnostics labs, positioning it at the intersection of precision medicine and digital transformation in pathology.
Competitive Landscape
Pro stress-test →Proscia was named as Leader among 15 other companies, including Philips, Ibex, and PathAI. Direct competitors in AI-powered digital pathology include PathAI (focused on machine learning-driven diagnosis), 4D Path, Techcyte, Imagene AI, Qritive, and Pathology Watch, but Proscia's scale advantage (serving 14 of top 20 pharma) and open-architecture integration strategy differentiate its positioning.
Industry Context
Proscia Inc. operates in AI-powered digital pathology platforms.
Key facts
Founded: 2014 · Headquarters: Philadelphia, US